Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Eps Article
This is a selection made from among articles on Drug Treatment Eps. For a permanent link to this article, or to bookmark it for future reading, click here.
Alcohol Rehab, Getting Help
from:
Often times, people who need help the most don’t get it. Unfortunately, for those who need to have alcohol rehab, many will not even have the opportunity. If you look at the faces of those people in rehab, you will see that they are the lucky ones. Many others, in slightly better or worse states of alcohol abuse will never make it this far. But, for those that are in alcohol rehab, they have the opportunity to pull through this disease and get the help they need and never touch a bottle or a drink again.
It is quite scary to realize that many individuals who get alcohol rehab are those that have been charged countless times with drunk driving. Unfortunately, it is not easy for any parent to realize that their child is learning to drive on a road surrounded by people who drink and drive. But, the reality is that most of the individuals who get into rehab only do it because they are being forced into it by law. This is simply not the right road to take.
Instead, for those who need help now, before they get behind the wheel of a car it is important to seek out that help. If you think about yourself for a moment, and think about how you feel about your drinking, you will find that deep down you know you need help. For those who think about the next drink, for those who wonder how they will pay for their next drink or those who get angry when someone asks if they have a problem…these are the people that need to seek help.
Alcohol rehab is not easy. But, it is life changing. It can take a person who is broken by the drug called alcohol and put them on the road to recovery. It is not simple. It is not painless. It is challenging work. But, for those that make it through alcohol rehab, it is the most rewarding of all experiences. It proves to them that they are stronger than any drug and their will power can and will see them through. For anyone who needs help, alcohol rehab centers are available in most cities. Take the first step and never look back at the horrible truths behind you.
About Author
Find more information and tips about alcohol rehab by visiting http://www.alcoholrehabnews.info
Source: ArticleTrader.com
Drug Treatment Eps Specific links
Drug Treatment Eps News
Altria Resolves Tax Dispute with IRS Regarding Philip Morris Capital ... - MarketWatch (press release)
Altria Resolves Tax Dispute with IRS Regarding Philip Morris Capital ... MarketWatch (press release) Altria Group, Inc. (Altria) (NYSE:MO) today announced that it has executed a Closing Agreement (Agreement) with the Internal Revenue Service (IRS) that, subject to court approval, resolves the federal income tax treatment for all prior tax years of ... |
Pfizer profits solid despite Lipitor loss - Reuters
Pfizer profits solid despite Lipitor loss Reuters * Q1 EPS $0.58, vs $0.56 forecast * Q1 sales $15.41 bln, versus $15.47 bln forecast * Lipitor sales plunge 42 percent to $1.4 billion * Shares down 0.7 pct By Ransdell Pierson May 1 (Reuters) - Pfizer Inc reported higher-than-expected quarterly ... |
Earnings Preview: Medtronic - Zacks.com
 Dividend.com | Earnings Preview: Medtronic Zacks.com Although Spine, struggling with its headwinds, will continue to disappoint, sales of the CardioVascular segment will benefit from the recent launch of the Resolute Integrity drug eluting stent for the treatment of coronary artery disease. Medtronic Posts Mixed Numbers |
Salix Beats; Ups EPS Outlook - Zacks.com
Salix Beats; Ups EPS Outlook Zacks.com Salix initiated a re-treatment study, TARGET 3, in Feb. 2012 with Xifaxan 550 mg for the treatment of irritable bowel syndrome (IBS) with diarrhea. The company had received a Complete Response Letter (CRL) for its supplemental New Drug Application ... Salix Q1 Results Beat Estimates; Raises EPS Guidance |
IBD 50: Coinstar, 5 Top Small Caps Boast Big Earnings - Investor's Business Daily
IBD 50: Coinstar, 5 Top Small Caps Boast Big Earnings Investor's Business Daily Questcor has gotten tremendous traction with its lone drug Acthar, a treatment for multiple sclerosis and other diseases. Earnings have soared in the last four quarters — 53%, 95%, 292% and 205%. Analysts look for a 139% jump in EPS to 55 cents this ... |
Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year ... - MarketWatch (press release)
Perrigo Reports Record Third Quarter Revenue And Earnings And Raises Full Year ... MarketWatch (press release) On March 1, 2012, the Company announced that it initiated market launch and made its first shipments of Minoxidil 5% Foam, comparable to Rogaine® 5% Foam Hair Regrowth Treatment, to its retail and wholesale customers. Nutritionals segment net sales for ... |
Citigroup Lowers Price Target on Teva Pharmaceutical Industries Ltd (TEVA) - Junction Report
 Dividend.com | Citigroup Lowers Price Target on Teva Pharmaceutical Industries Ltd (TEVA) Junction Report Analysts expect that Teva Pharmaceutical Industries Ltd will post $1.34 EPS next quarter. Teva Pharmaceutical Industries Limited (Teva) is a global pharmaceutical and drug company. It develops, produces and markets generic drugs in all treatment ... Auriga Starts Stock Coverage on Teva Pharmaceutical Industries Ltd (TEVA) |
Orbimed's $3.4B Filing: 2 Stocks It And Other Healthcare Funds Bought In Q1 ... - Seeking Alpha
Orbimed's $3.4B Filing: 2 Stocks It And Other Healthcare Funds Bought In Q1 ... Seeking Alpha Its primary product is HP Acthar Gel, an injectable drug that is approved for the treatment of exacerbations associated with multiple sclerosis, infantile spasms, opsoclonus myoclonus syndrome and nephrotic syndrome. Orbimed added $60 million in Q1 to ... |
McKesson 4th-qtr profit rises, forecast in line - Reuters
McKesson 4th-qtr profit rises, forecast in line Reuters * Fiscal Q4 EPS $2.09 vs Street view $2.06 * Revenue up 10 pct to $31.7 billion * Sees fiscal 2013 EPS $7.05 to $7.35 By Bill Berkrot April 30 (Reuters) - Pharmaceutical wholesaler McKesson Corp on Monday reported a higher quarterly profit on a 10 ... |
Johnson & Johnson Could Slip 5% On Lower Margins - Seeking Alpha
Johnson & Johnson Could Slip 5% On Lower Margins Seeking Alpha Additionally, with doctors and patients outraged over drug scandals like the recent discovery of high levels of chromium in certain capsules, consumption could decline, leaving Johnson & Johnson and others with empty pockets. |